The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Protara Therapeutics, Inc(NASDAQ:TARA) 
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformation...
Share this website to your friends
Protara Therapeutics Days Payable Outstanding ttm (DPO)
Protara Therapeutics Days Inventory Outstanding ttm (DIO)
Protara Therapeutics Op Cashflow Per Share ttm
Protara Therapeutics Free Cashflow Per Share ttm
Protara Therapeutics Cash Per Share ttm
Protara Therapeutics (GAAP) P/E ratio ttm
Protara Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.